SAN DIEGO, March 28, 2011 /PRNewswire/ -- TriLink BioTechnologies, Inc. (TriLink) announced that it has entered into a distribution agreement with TATAA Biocenter (TATAA) to sell its CleanAmp™ Products. The Scandinavian based TATAA develops and performs a broad spectrum of hands-on qPCR courses worldwide, in addition to providing tailor-made products for real-time PCR applications.
As an innovative approach to Hot Start PCR, TriLink's CleanAmp™ Product Line is an ideal complement to TATAA's product and service offerings. In developing CleanAmp™, TriLink applied its expertise in modified nucleic acid chemistry to resolve common PCR problems, such as primer dimer formation and mis-priming. This advancement in Hot Start technology employs two widely ignored components of the PCR reagent mix: the primers and the dNTPs. The latest addition to the CleanAmp™ Product Line will be new, improved CleanAmp™ dNTPs, which will be available in April 2011. The latest advancement in CleanAmp™ dNTP chemistry allows improved amplicon yield in endpoint PCR and earlier Cq values in fast cycling real-time PCR.
"TATAA has established itself as a thought leader in the field of real-time PCR, and we are excited about the opportunity to expose our CleanAmp™ technology to the international research community through its training courses. We are confident that TATAA and its clients will be pleased with the results they see using CleanAmp™ Products," stated TriLink's President and CEO, Richard Hogrefe.
"The CleanAmp™ hot-start technique developed at TriLink is so much more versatile and easy to implement compared to alternatives, and being supported by our application specialists, we expect it will become a most popular product," says Mikael Kubista, founder and CEO of TATAA Biocenter.
About TriLink
TriLink manufactures custom oligonucleotides, modified nucleoside triphosphates and CleanAmp™ PCR products for the research, diagnostic and OEM markets. In addition, custom chemistry, contract research services and ISO/QSR compliant cGMP production facilities are offered. TriLink's solutions help advance drug discovery and biomedical research. Founded in 1996, TriLink is a privately held firm based in San Diego, California and employs approximately 85 scientists and other professionals. For more information about the firm and products, call 858-546-0004, email [email protected], or visit our web site at www.trilinkbiotech.com.
About TATAA Biocenter
TATAA Biocenter is one of the leading research and service providers and organizers of hands-on training courses in qPCR in Europe. They offer a full range of real-time qPCR services including high throughput qPCR analysis, primer and probe design and validation, data analysis, testing and evaluation of kits and instruments, and contract research to Pharmaceutical and Biotech companies among others. Founded in 2001, TATAA has permanent facilities in Gothenburg, Sweden, Sunnyvale, California, and Prague, Czech Republic.
For more information about the CleanAmp™ products in Europe see www.tataa.com or contact TATAA head of sales, Ara Rofooragan ([email protected], +46 (707) 731098).
SOURCE TriLink BioTechnologies, Inc.
Advertisement
As an innovative approach to Hot Start PCR, TriLink's CleanAmp™ Product Line is an ideal complement to TATAA's product and service offerings. In developing CleanAmp™, TriLink applied its expertise in modified nucleic acid chemistry to resolve common PCR problems, such as primer dimer formation and mis-priming. This advancement in Hot Start technology employs two widely ignored components of the PCR reagent mix: the primers and the dNTPs. The latest addition to the CleanAmp™ Product Line will be new, improved CleanAmp™ dNTPs, which will be available in April 2011. The latest advancement in CleanAmp™ dNTP chemistry allows improved amplicon yield in endpoint PCR and earlier Cq values in fast cycling real-time PCR.
Advertisement
"TATAA has established itself as a thought leader in the field of real-time PCR, and we are excited about the opportunity to expose our CleanAmp™ technology to the international research community through its training courses. We are confident that TATAA and its clients will be pleased with the results they see using CleanAmp™ Products," stated TriLink's President and CEO, Richard Hogrefe.
"The CleanAmp™ hot-start technique developed at TriLink is so much more versatile and easy to implement compared to alternatives, and being supported by our application specialists, we expect it will become a most popular product," says Mikael Kubista, founder and CEO of TATAA Biocenter.
About TriLink
TriLink manufactures custom oligonucleotides, modified nucleoside triphosphates and CleanAmp™ PCR products for the research, diagnostic and OEM markets. In addition, custom chemistry, contract research services and ISO/QSR compliant cGMP production facilities are offered. TriLink's solutions help advance drug discovery and biomedical research. Founded in 1996, TriLink is a privately held firm based in San Diego, California and employs approximately 85 scientists and other professionals. For more information about the firm and products, call 858-546-0004, email [email protected], or visit our web site at www.trilinkbiotech.com.
About TATAA Biocenter
TATAA Biocenter is one of the leading research and service providers and organizers of hands-on training courses in qPCR in Europe. They offer a full range of real-time qPCR services including high throughput qPCR analysis, primer and probe design and validation, data analysis, testing and evaluation of kits and instruments, and contract research to Pharmaceutical and Biotech companies among others. Founded in 2001, TATAA has permanent facilities in Gothenburg, Sweden, Sunnyvale, California, and Prague, Czech Republic.
For more information about the CleanAmp™ products in Europe see www.tataa.com or contact TATAA head of sales, Ara Rofooragan ([email protected], +46 (707) 731098).
SOURCE TriLink BioTechnologies, Inc.
